Generali Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Generali Asset Management's REGN Position: Q3 2026 in Review
Generali Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 12% in Q3 2026, selling an estimated $685K and leaving 6,779 shares worth $5.14M. The position accounts for 0.09% of the portfolio, ranked #190.
Generali Asset Management first reported a position in REGN in Q4 2024 and has held it in 8 quarters since. The position peaked at $8.09M in Q4 2024. 1,432 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Generali Asset Management held 6,779 shares of Regeneron Pharmaceuticals worth $5.14M as of Q3 2026.
- Generali Asset Management sold 906 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $685K.
- Regeneron Pharmaceuticals made up 0.09% of Generali Asset Management's portfolio in Q3 2026, its #190 holding.
- Generali Asset Management first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
- Generali Asset Management's Regeneron Pharmaceuticals position peaked at $8.09M in Q4 2024.
- 1,432 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Generali Asset Management's 13F filing for Q3 2026, filed 26 Oct 2026.